Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) were up 8.9% on Wednesday . The company traded as high as $39.87 and last traded at $39.70. Approximately 317,490 shares traded hands during mid-day trading, an increase of 3% from the average daily volume of 309,719 shares. The stock had previously closed at $36.44. Wall […]
SG Americas Securities LLC lifted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 138.8% during the 4th quarter, HoldingsChannel reports. The fund owned 10,588 shares of the company’s stock after purchasing an additional 6,154 shares during the period. SG Americas Securities LLC’s holdings in Amphastar Pharmaceuticals were worth $297,000 at […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) was the target of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 1,310,000 shares, a drop of 10.3% from the March 15th total of 1,460,000 shares. Based on an average trading volume of 286,100 shares, the […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) CFO William J. Peters sold 5,632 shares of Amphastar Pharmaceuticals stock in a transaction that occurred on Monday, April 17th. The stock was sold at an average price of $42.35, for a total transaction of $238,515.20. Following the transaction, the chief financial officer now directly owns 105,148 shares […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) reached a new 52-week high during trading on Monday . The stock traded as high as $42.35 and last traded at $41.72, with a volume of 41301 shares changing hands. The stock had previously closed at $42.15. Analyst Upgrades and Downgrades Separately, StockNews.com upgraded Amphastar Pharmaceuticals from a […]